Concepedia

Joseph Gera

JG

55

Publications

4.2K

Citations

32

H-Index

1990

Active since

Affiliations

University of California, Los Angeles(Current)

VA Greater Los Angeles Healthcare System

UCLA Jonsson Comprehensive Cancer Center

UCLA Medical Center

Ronald Reagan UCLA Medical Center

Joseph Gera is an author at University of California, Los Angeles specializing in cell biology, medicine, and cell signaling.

ORCID

Top concepts

Publications per year

1990–2023

55

Publications

55

Mammalian target of rapamycin inhibitors activate the AKT kinase in multiple myeloma cells by up-regulating the insulin-like growth factor receptor/insulin receptor substrate-1/phosphatidylinositol 3-kinase cascade

Yijiang Shi, Huajun Yan, Patrick Frost et al. · Molecular Cancer Therapeutics · 2005 · 369 citations · Full text

AKT Activity Determines Sensitivity to Mammalian Target of Rapamycin (mTOR) Inhibitors by Regulating Cyclin D1 and c-myc Expression

Joseph Gera, Ingo K. Mellinghoff, Yijiang Shi et al. · Journal of Biological Chemistry · 2004 · 329 citations · Full text

, , +17

Oncogenic EGFR Signaling Activates an mTORC2–NF-κB Pathway That Promotes Chemotherapy Resistance

Kazuhiro Tanaka, Ivan Babić, David A. Nathanson et al. · Cancer Discovery · 2011 · 278 citations · Full text

mTORC2 Activity Is Elevated in Gliomas and Promotes Growth and Cell Motility via Overexpression of Rictor

Janine Masri, Andrew Bernath, Jheralyn Martin et al. · Cancer Research · 2007 · 254 citations

Enhanced sensitivity of multiple myeloma cells containing PTEN mutations to CCI-779.

Yijiang Shi, Joseph Gera, Liping Hu et al. · PubMed · 2002 · 234 citations

, , +13

Rows per page

1–5 of 55